camel-ids
Verified IntelCamel-IDS is a biotech company developing targeted radionuclide therapeutic solutions against cancer. Camel-IDS was incorporated on October 14th 2014 in Brussels, Belgium to leverage a technology platform that has been developed at VUB (Vrije Universiteit Brussel). Camel-IDS is based on recombinant, small antigen-binding fragments derived from Camelidae heavy-chain-only antibodies (Camelids), coupled with a therapeutic radioisotope. Camelids are used to transport the radioisotope to selected cancer receptors on the cancer cell surface and will selectively kill cancer cells by irradiation.
Camel-IDS is a biotech company developing targeted radionuclide therapeutic solutions against cancer. Camel-IDS was incorporated on October 14th 2014 in Brussels, Belgium to leverage a technology platform that has been developed at VUB (Vrije Universiteit Brussel). Camel-IDS is based on recombinant, small antigen-binding fragments derived from Camelidae heavy-chain-only antibodies (Camelids), coupled with a therapeutic radioisotope. Camelids are used to transport the radioisotope to selected cancer receptors on the cancer cell surface and will selectively kill cancer cells by irradiation.
Corporate Firmographics
Entity classification and operating profile
- Industry
- Biotechnology
- Company Type
- Privately Held
- Founded
- Undisclosed
- Employee Bracket
- 11-50
- Estimated Revenue Range
- Undisclosed
Geographic Coordinates
Headquarters address and regional territory
- Street Address
- Burgemeester Etienne Demunterlaan 1 Brussels
- City
- Ghent
- Region / State
- Oost-Vlaanderen
- Postal Code
- 1090
- Country
- Belgium
Digital Presence & Footprint
Verified domains, socials, and directory profiles
Frequently Asked Questions
Verified business inquiries and firmographic telemetry for camel-ids.